Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001280652 | SCV001467928 | benign | not specified | 2020-12-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002357071 | SCV002655154 | likely benign | Cardiovascular phenotype | 2019-07-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002541751 | SCV003246777 | likely benign | not provided | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002541751 | SCV005265806 | benign | not provided | criteria provided, single submitter | not provided |